Ekipa studije sada planira istraživanja na većem broju pacijenata, kao i na drugim čvrstim tumorima (npr. želuca, pankreasa i bešike).
Kažu da se nove terapije za rak sada pojavljuju tipa jednom mesečno, dok je pre nekoliko godina to bilo jednom godišnje.
Studija:
https://www.nejm.org/doi/full/10.1056/NEJMoa2201445
Detaljnije iz medija:
A trial group of people with rectal cancer just experienced something of a scientific miracle: their cancer vanished after an experimental treatment.
— NPR (@NPR) June 7, 2022
Patients took a drug called dostarlimab for six months which resulted in their tumors disappearing. https://t.co/LvuNvE4LnW
"There were a lot of happy tears."
— The New York Times (@nytimes) June 5, 2022
It was a small trial, just 18 rectal cancer patients, every one of whom took the same drug.
But the results were astonishing. The cancer vanished in every single patient. https://t.co/mYnlfUkKAs
A small drug trial is having a seismic impact in the world of oncology: After six months of an experimental treatment, tumors vanished in all 14 patients diagnosed with early stage rectal cancer who completed the study by the time it was published. https://t.co/3KHYjD3ZeH
— The Washington Post (@washingtonpost) June 8, 2022